Atrial Flutter
📧 Sign up to get email alerts when something new happens for Atrial Flutter.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2018-05-17Clinical Trial Update: Evaluation of the Safety, Feasibility and Usability of the EPD D700 System in Atrial Flutter Ablation Procedures [NA]
The trial evaluating the EPD D700 System for atrial flutter ablation has been withdrawn, with no results reported.
-
CLINICAL_TRIALS withdrawal · 2017-05-02Clinical Trial Update: Pulmonary Vein Isolation To Reduce Future Risk Of Atrial Fibrillation In Patients Undergoing Typical Flutter [NA]
The trial investigating pulmonary vein isolation to reduce future atrial fibrillation risk in patients with typical atrial flutter has been …
-
EMA withdrawal · 2009-12-31EMA Withdrawn: Tikosyn (dofetilide) — Pfizer Limited
Tikosyn (dofetilide) has been withdrawn in the EU by Pfizer Limited, with the medicinal product no longer authorized for use.
-
EMA withdrawal · 2006-09-08EMA Application withdrawn: Multaq (dronedarone) — Sanofi-Aventis
EMA withdrew the application for Multaq (dronedarone) for atrial fibrillation/flutter.